Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality

被引:16
作者
Berton, G
Cordiano, R
Palmieri, R
Toni, R
Guarnieri, G
Palatini, P
机构
[1] Univ Padua, Dept Clin & Expt Med, I-35128 Padua, Italy
[2] Conegliano Gen Hosp, Dept Internal Med & Cardiol, Conegliano, Italy
[3] Adria Gen Hosp, Dept Internal Med & Cardiol, Adria, Italy
关键词
acute myocardial infarction; albumin; creatinine ratio; albumin excretion; diabetes mellitus; microalbuminuria; mortality;
D O I
10.1007/s00125-004-1486-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Diabetes mellitus is associated with increased mortality in subjects with acute myocardial infarction (AMI). We aimed to estimate the risk of mortality in AMI patients with and without diabetes using the urinary albumin : creatinine ratio (ACR). Methods. This is a prospective study of 121 consecutive, non-selected diabetic AMI patients, 121 age- and sex-matched non-diabetic AMI patients and 61 diabetic non-AMI outpatients as control subjects. All data were obtained during the first 7 days of hospitalisation and each AMI patient was followed for a period of exactly 3 years. Baseline ACR RIA measurements were made on the 1st, 3rd and 7th days of admission. Results. Adjusted ACR values were significantly higher in the diabetic AMI patients than in the diabetic control outpatients (p<0.0001), and a significant difference was observed between the weekly ACR slopes for these two groups (p<0.0001). Microalbuminuria was more prevalent in the diabetic AMI patients than in the non-diabetic AMI patients on the 1st day (62% vs 46%, p=0.01) and 3rd day (41% vs 29%, p=0.04). Among the AMI patients with normoalbuminuria (ACR <30 mug/mg), the mortality rate was 11.6% for the patients without diabetes and 33.8% for those with diabetes (p=0.001). The mortality rate was much higher among the AMI patients with microalbuminuria (ACR greater than or equal to30 mug/mg) and similar for the diabetic (68.0%) and non-diabetic patients (74.3%). In a multivariable Cox model, ACR (p<0.0001) and diabetes status (p=0.01) were associated with adverse outcome even when several other clinical variables were included in the model. Furthermore, a negative interaction was found between diabetes and ACR (p=0.01). Conclusions/interpretation. Microalbuminuria frequently occurs in diabetic and non-diabetic AMI patients during the first 3 days of admission to hospital and can be used to identify subjects at high risk of mortality.
引用
收藏
页码:1511 / 1518
页数:8
相关论文
共 30 条
  • [21] EFFECT OF PROTEINURIA ON MORTALITY IN NIDDM
    NELSON, RG
    PETTITT, DJ
    CARRAHER, MJ
    BAIRD, HR
    KNOWLER, WC
    [J]. DIABETES, 1988, 37 (11) : 1499 - 1504
  • [22] Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension
    Pedrinelli, R
    Dell'Omo, G
    Di Bello, V
    Pontremoli, R
    Mariani, M
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (02) : 79 - 89
  • [23] PIEMONTINO U, 1994, HAEMATOLOGICA, V79, P387
  • [24] A new look at the heart in diabetes mellitus: from ailing to failing
    Standl, E
    Schnell, O
    [J]. DIABETOLOGIA, 2000, 43 (12) : 1455 - 1469
  • [25] URINARY ALBUMIN EXCRETION, CARDIOVASCULAR-DISEASE, AND ENDOTHELIAL DYSFUNCTION IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    STEHOUWER, CDA
    NAUTA, JJP
    ZELDENRUST, GC
    HACKENG, WHL
    DONKER, AJM
    DENOTTOLANDER, GJH
    [J]. LANCET, 1992, 340 (8815) : 319 - 323
  • [26] C-reactive protein modifies the relationship between blood pressure and microalbuminuria
    Stuveling, EM
    Bakker, SJL
    Hillege, HL
    Burgerhof, JGM
    de Jong, PE
    Gans, ROB
    de Zeeuw, D
    [J]. HYPERTENSION, 2004, 43 (04) : 791 - 796
  • [27] Tuomilehto J, 2003, DIABETES CARE, V26, P61
  • [28] Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy:: The LIFE study
    Wachtell, K
    Ibsen, H
    Olsen, MH
    Borch-Johnsen, K
    Lindholm, LH
    Mogensen, CE
    Dahlöf, B
    Devereux, RB
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Kristianson, K
    Lederballe-Pedersen, O
    Nieminen, MS
    Okin, PM
    Omvik, P
    Oparil, S
    Wedel, H
    Snapinn, SM
    Aurup, P
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (11) : 901 - 906
  • [29] Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-I experience
    Woodfield, SL
    Lundergan, CF
    Reiner, JS
    Greenhouse, SW
    Thompson, MA
    Rohrbeck, SC
    Deychak, Y
    Simoons, ML
    Califf, RM
    Topol, EJ
    Ross, AM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) : 1661 - 1669
  • [30] INFLUENCE OF DIABETES ON MORTALITY IN ACUTE MYOCARDIAL-INFARCTION - DATA FROM THE GISSI-2 STUDY
    ZUANETTI, G
    LATINI, R
    MAGGIONI, AP
    SANTORO, L
    FRANZOSI, MG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (07) : 1788 - 1794